Casi Pharmaceuticals, Inc. shares fall 5.15% intraday amid broader market downturn.

Casi Pharmaceuticals, Inc. declined 5.15% in intraday trading. The news event related to the stock is the ruling by U.S. District Judge Allison Burroughs of Massachusetts, which comes as Harvard and the Trump administration have been in talks to resolve months of the government's pressure tactics over what it calls antisemitism and diversity-related concerns. President Trump said last month that he wants no less than $500 million from Harvard, telling Education Secretary Linda McMahon during a cabinet meeting: 'They've been very bad. Don't negotiate.